Try our beta test site
2 studies found for:    "RWJMS" OR "Robert Wood Johnson Medical School" OR "Cancer Institute of New Jersey" OR "CINJ" | Open Studies | "Lymphoma, Large B-Cell, Diffuse"
Show Display Options
Rank Status Study
1 Recruiting A Study of Obinutuzumab, Polatuzumab Vedotin, and Venetoclax in Relapsed or Refractory Follicular Lymphoma (FL) or Diffuse Large B-Cell Lymphoma (DLBCL)
Condition: Non-Hodgkin's Lymphoma
Interventions: Drug: Obinutuzumab;   Drug: Polatuzumab Vedotin;   Drug: Venetoclax
2 Recruiting Study of CC-122 to Evaluate the Safety, Tolerability, and Effectiveness for Patients With Advanced Solid Tumors, Non-Hodgkin's Lymphoma, or Multiple Myeloma
Conditions: Multiple Myeloma;   Lymphoma, Large B-Cell, Diffuse;   Pleiotropic Pathway Modifier;   Glioblastoma;   Lymphoma;   Primary Central Nervous System Lymphoma (PCNSL)
Intervention: Drug: CC-122

Study has passed its completion date and status has not been verified in more than two years.